Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-24

Clinical Trial Update: Topical Avastin for Treatment of Corneal Neovascularization [Phase 1]

View source ↗

Summary

Phase 1 trial update on topical Avastin for corneal neovascularization has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Corneal Neovascularization | Phase 1 | Status: COMPLETED | Results posted: 2012-09-24